Trial NCT03952585

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2019-03015
Secondary IDs: NCI-2019-03015 NRG-HN005 U10CA180868

Last trial update was posted on 2024-04-16

MeSH Interventions

Cisplatin Deoxyglucose Fluorodeoxyglucose F18 Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Oropharyngeal Neoplasms Squamous Cell Carcinoma of Head and Neck

Other Conditions

Basaloid Squamous Cell Carcinoma Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Oropharyngeal Squamous Cell Carcinoma Papillary Squamous Cell Carcinoma Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Squamous Cell Carcinoma

Stopping Reasons

End of Initial Phase of Multi-phase protocol

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID